CIAM
IGMS

Caitong International Asset Management’s IGM Biosciences IGMS Stock Holding History

Caitong International Asset Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-169
Closed -$1.03K – 2342
2024
Q4 		$1.03K Buy
+169
New +$2.01K ﹤0.01% 1323

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Caitong International Asset Management's IGMS Position: Q1 2025 in Review

Caitong International Asset Management sold out of IGM Biosciences (IGMS) in Q1 2025, closing a stake of 169 shares — an estimated $1.03K sold.

Caitong International Asset Management first reported a position in IGMS in Q4 2024 and held it in 1 quarter. The position peaked at $1.03K in Q4 2024. 79 funds tracked by Wall St. Rank hold IGMS as of Q1 2025.

  • Caitong International Asset Management reported no remaining IGM Biosciences position as of Q1 2025 after selling out during the quarter.
  • Caitong International Asset Management sold 169 IGM Biosciences shares in Q1 2025, an estimated $1.03K.
  • Caitong International Asset Management first reported a position in IGM Biosciences in Q4 2024 and held it in 1 quarter.
  • Caitong International Asset Management's IGM Biosciences position peaked at $1.03K in Q4 2024.
  • 79 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2025.

Based on Caitong International Asset Management's 13F filing for Q1 2025, filed 13 May 2025.